Share
Patient Monitoring Devices Market Segments: By Type (Hemodynamic Monitoring, Neuromonitoring, Cardiac Monitoring, Fetal & Neonatal Monitoring, Respiratory Monitoring, Multi-Parameter Monitoring, Remote Patient Monitoring, Weigh Monitoring, And Temperature Monitoring Devices); By End User (Hospitals & Clinics, Home Settings, and Ambulatory Surgical Centers); and Region - Analysis of Market Size, Share & Trends for 2014 - 2019 and Forecasts to 2030
[ 170 + Pages Research Report ] Patient Monitoring Devices Market to surpass USD 60.3 Billion by 2030 from USD 20.2 billion in 2018 in terms of value growing at a CAGR of 6.2% throughout the forecast period, i.e., 2019-30.
Patient monitoring devices are a technology used to collect and electronically transmit medical and health-related data from individuals at one location to a healthcare provider at another location. Patient monitoring equipment continuously tracks the patient’s vital health signs, such as respiratory rate, heart rate, rhythm, blood pressure, saturation of blood oxygen, and many other parameters. These devices assist in examining the health condition of a patient and provide healthcare professionals with timely warnings about the delivery of medical services to the patient. Continuous patient monitoring has been found to have enabled early detection of patient deterioration and early treatment. Besides, wearable patient monitoring systems have provided patients with wireless technology with freedom and comfort.
Patient Monitoring Devices Market to surpass USD 60.3 Billion by 2030 from USD 20.2 billion in 2018 in terms of value growing at a CAGR of 6.2% throughout the forecast period, i.e., 2019-30. A key trend in inpatient care is the integration of monitoring technologies into smartphones and wireless devices, leading to the introduction of remote monitoring systems, mobile cardiac telemetry devices, mobile personal digital assistant (PDA) systems, outpatient wireless EEG recorders, and outpatient event monitors, which are key factors that support market growth. The market has been accelerated by the change in lifestyle patterns and the increasing cases of chronic diseases among the global population. Factors such as the easy availability of wireless monitoring devices and the rising incidence of lifestyle and chronic diseases are expected to drive market growth during the forecast period.
The Patient Monitoring Devices Market is segmented by type as hemodynamic monitoring, neuromonitoring, cardiac monitoring, fetal & neonatal monitoring, respiratory monitoring, multi-parameter monitoring, remote patient monitoring, weight monitoring, and temperature monitoring devices. The cardiac monitoring devices segment is estimated to lead the market with a share of over 26.0% of in Patience monitoring device market in 2018 and this trend is expected to continue during the forecast period. This is attributed to an increase in the prevalence of different cardiovascular diseases throughout the world each year, such as congestive heart failure and stroke. The segment is rapidly gaining popularity among patients with chronic diseases such as diabetes, hypertension, and chronic respiratory diseases because remote patient monitoring devices can be used remotely to monitor critical parameters of patients. It is therefore expected to be the fastest-growing segment registering a CAGR of 6.7% during the forecast period.
The Patient Monitoring Devices Market is segmented by End-user into hospitals, ambulatory surgery centers, home care settings, and others. The Ambulatory surgical centers emerged as the leading end-user segment in 2018 and accounted for over XX.X of the market share. During the forthcoming years, the ambulatory surgical centers segment is estimated to see around 6 percent growth. In developed economies, a large number of populations are inclined toward ASCs, as they are equipped with advanced patient monitoring devices and well-developed infrastructure. In ASCs, the conventional type of patient monitoring device is particularly preferred because it is cost-effective. Various advantages, such as the reduced risk of hospital-acquired infection, shorter hospital stay, and quality treatment, increase patient preference for ASCs, fostering the size of the market. The presence of advanced ICUs and emergency wards in hospitals and the increasing number of surgical procedures can primarily be attributed to significant market growth and a large share of the hospital segment.
Rising Burden of Chronic Diseases
Chronic heart disease, diabetes, and chronic respiratory diseases are the world's leading causes of mortality and morbidity. 75% of healthcare costs are accounted for by chronic care management. The rise in the prevalence of chronic circumstances places a huge financial burden on caregivers. It thus decreases readmissions and prevents avoidable hospitalizations. Besides, these technologies reduce the number of unnecessary trips to the doctor's office and reduce the travel costs required to receive quality medical care. Therefore, it is expected that the increasing focus on a healthy lifestyle, the increasing trend of self-monitoring and preventive medicine, and the growing concern for constant monitoring of patient health parameters will drive the growth of the overall market.
Growing Preference for Home and Remote Monitoring
Due to the increasing prevalence of cardiovascular diseases worldwide, the cardiac monitoring devices segment valuation in 2019 was over USD 2.4 billion. Different surgical treatments are performed on a large population base suffering from cardiovascular diseases and require accurate monitoring of vital parameters affecting the market growth. Besides, manufacturers such as Medtronic have introduced technologically advanced products to obtain accurate information that further stimulates the expansion of the market for better patient care. A few applications for wearable patient monitoring devices, biosensors, and smart implants are continuous glucose monitoring, temperature monitoring, blood pressure monitoring, and pulse oximetry. The Internet of Things technology is equipped with new-generation wearable devices that increase remote monitoring.
The risk associated with invasive monitoring devices
Several risks are associated with the use of invasive monitoring systems, such as discomfort associated with the insertion of monitoring tools, such as pulmonary artery catheters (PAC). Some other major risks are air embolism, sepsis, bleeding/hematoma formation, cardiac arrhythmias, decreased distal limb circulation, hemorrhage, damage to the nerves (during insertion), thrombosis, air embolism, and pulmonary capillary necrosis. The mortality rate during invasive procedures is increased by these factors. Consequently, the risks mentioned above limit the use of invasive monitoring devices.
Abbott Laboratories
The Patient Monitoring Devices Market is segmented based on regional analysis into five major regions. These include North America, Latin America, Europe, APAC, and MENA.
The Patient Monitoring Devices Market in North America led the market in 2018. The key factors supporting market growth in North America are increasing R&D to develop novel sensor-based patient monitoring systems, increasing infectious disease prevalence, safety concerns, and technological advances in patient monitoring device products. Besides, most of the world's leading companies are headquartered in the region or have a strong presence in that market, another key factor that is attributed to the market's significant growth. Europe, particularly Western European countries, is expected to remain the second most profitable region over the forecast period due to a higher mortality rate and rising demand for low-cost treatment. High-impact drivers for regional growth are increasing demand for in-house monitoring, supportive central data management systems, and increasing the accuracy and efficiency of remote patient monitoring systems.
The Patient Monitoring Devices market, which is highly competitive, consists of several major players such as Abbott Laboratories (US), HILL-ROM HOLDINGS, INC. (US), Drägerwerk AG & Co. KGaA (Germany) hold a substantial market share in the Patient Monitoring Devices market. Other players analyzed in this report are Edwards Lifesciences Corporation (US), OMRON Corporation (Japan), Masimo Corporation (US), Compumedics Limited (Australia), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), Nihon Kohden Corporation (Japan), Natus Medical (US), Medtronic plc (Ireland), Koninklijke Philips N.V. (Netherlands), GE Healthcare (US), Getinge AB (Sweden), Boston Scientific Corporation (US), Dexcom, Inc. (US), Nonin (US), BIOTRONIK (Germany), SCHILLER (Switzerland), and BioTelemetry, Inc. (the US), among others.
Key players are adopting inorganic growth strategies such as product launches in the global nutritional supplement market. For instance, In December 2019, Masimo Corporation received FDA approval for the Neonatal RD SET Pulse Oximetry Sensors. Clinical studies have shown that the use of these oximeters reduces severe retinopathy in neonates.
North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – the United States and Canada
Patient Monitoring Devices Market Segments:
Select License Type
Select License Type
FATPOS CLIENT Appriciation DURING THE PROJECT
Working with Fatpos Global, allowed us to take advantage of their knowledge and easy approach, allowing us to collect important data utilizing a variety of techniques. The results were clearly presented and explained, and FG responded to our questions with speed and expertise.
|
Swiss-based global building materials manufacturer |
The analyses and presentations Fatpos Global have produced for us have been of a very high caliber and have allowed us to proactively improve our customer relationship management. They have also done so while maintaining complete anonymity. Without any doubt, we suggest Fatpos Global to you.
|
|
Tech-powered construction company |
We appreciate the team’s punctuality, flexibility in terms of report modification, post report purchase support and pleasant reaction all around. Overall, my experience with this company was nothing but positive, and I couldn't be more grateful for their excellent service. Thank you for all that you do!
|
|
American global management consulting firm |
We are able to concentrate on the topics and implications that are most important to our clients thanks to the adaptability and responsiveness of the team at Fatpos Global. We would highly recommend this company to anyone in need of their services, and I will certainly be using them again in the future.
|
|
Headquartered in Zug, Switzerland, leading supplier of medical and surgical instrument |
To better study our client demographics, develop the ideal product-price architecture, and enhance our target marketing initiatives, we hired Fatpos Global. Every component of the project was completed, and we are very happy with the useful insights and actionable results.
|
|
Kosovan company, A leading organic fertilizers producer |
Thank you for your team's generous assistance, The final report was delivered to me, and I find it to be really helpful. Also, you may be sure that I will get in touch with you if I ever require fresh materials for market research. Gratitude once more.
|
|
German specialty chemicals company based in Cologne, Germany |
